New Dibenzoquinoxalines Inhibit Triple-Negative Breast Cancer Growth by Dual Targeting of Topoisomerase 1 and the c-MYC G-Quadruplex
Authors:
- 7 May 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 64 (10) , 6720-6729
Abstract
As c-MYC is one of the central players in triple-negative breast cancer (TNBC) oncogenesis, inhibiting c-MYC expression would be an effective anticancer strategy. Transcription-induced negative supercoiling is crucial in the regulation of c-MYC transcription, which facilitates the formation of a G4 structure in NHE III1 that can silence the transcription. However, topoisomerase 1 (Topo1) can dissipate this negative supercoiling, leading to continuous activation of c-MYC transcription. Thus, dual ligands targeting both Topo1 and c-MYC G4 appear to be significant in cancer therapy. In this study, a series of new dibenzoquinoxaline derivatives were designed, synthesized, and evaluated for both Topo1 and c-MYC inhibition. Among them, 5 was identified as the most promising dual ligand, which could effectively inhibit Topo1 activity and strongly stabilize c-MYC G4, thereby inhibiting cancer cell growth. Accordingly, this work suggests that this dual-targeting strategy may be effective in cancer therapy.Keywords
Funding Information
- National Natural Science Foundation of China (81803348)
- Natural Science Foundation of Guangdong Province (2018A030310580)
This publication has 26 references indexed in Scilit:
- Demonstration that Drug-targeted Down-regulation of MYC in Non-Hodgkins Lymphoma Is Directly Mediated through the Promoter G-quadruplexJournal of Biological Chemistry, 2011
- Solution Structure of a 2:1 Quindoline–c-MYC G-Quadruplex: Insights into G-Quadruplex-Interactive Small Molecule Drug DesignJournal of the American Chemical Society, 2011
- The Importance of Negative Superhelicity in Inducing the Formation of G-Quadruplex and i-Motif Structures in the c-Myc Promoter: Implications for Drug Targeting and Control of Gene ExpressionJournal of Medicinal Chemistry, 2009
- Modelling Myc inhibition as a cancer therapyNature, 2008
- The functional response of upstream DNA to dynamic supercoiling in vivoNature Structural & Molecular Biology, 2008
- Supercoil-driven DNA structures regulate genetic transactionsFrontiers in Bioscience-Landmark, 2007
- The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c‐myc expressionThe EMBO Journal, 2006
- c-MYC: more than just a matter of life and deathNature Reviews Cancer, 2002
- DNA Topoisomerases: Structure, Function, and MechanismAnnual Review of Biochemistry, 2001
- A Spectrophotometric Investigation of the Interaction of Iodine with Aromatic HydrocarbonsJournal of the American Chemical Society, 1949